Agenus (AGEN) Earnings Date & Reports

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AGEN is expected to report earnings to fall 98.53% to 1 cents per share on November 10

Q3'26

Est.

$0.01

Q1'26

Beat

by $1.67

Q4'25

Missed

by $0.04

Q3'25

Beat

by $2.22

Q2'25

Missed

by $0.73

The last earnings report on May 11 showed earnings per share of $1.02, beating the estimate of -64 cents. With 984.47K shares outstanding, the current market capitalization sits at 364.13M.

View a ticker or compare two or three

AGEN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days